GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (NAS:ADAG) » Definitions » Beneish M-Score
中文

Adagene (Adagene) Beneish M-Score : -1.98 (As of Apr. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Adagene Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.98 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Adagene's Beneish M-Score or its related term are showing as below:

ADAG' s Beneish M-Score Range Over the Past 10 Years
Min: -4.65   Med: 4.69   Max: 13.18
Current: -1.98

During the past 6 years, the highest Beneish M-Score of Adagene was 13.18. The lowest was -4.65. And the median was 4.69.


Adagene Beneish M-Score Historical Data

The historical data trend for Adagene's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagene Beneish M-Score Chart

Adagene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - 13.18 11.35 -4.65 -1.98

Adagene Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.35 0.39 -4.65 - -1.98

Competitive Comparison of Adagene's Beneish M-Score

For the Biotechnology subindustry, Adagene's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagene's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adagene's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Adagene's Beneish M-Score falls into.



Adagene Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Adagene for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.184+0.528 * 1+0.404 * 1.0166+0.892 * 1.9489+0.115 * 0.9245
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.3748+4.679 * 0.053738-0.327 * 0.8586
=-1.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.22 Mil.
Revenue was $18.11 Mil.
Gross Profit was $18.11 Mil.
Total Current Assets was $113.44 Mil.
Total Assets was $115.73 Mil.
Property, Plant and Equipment(Net PPE) was $2.20 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.21 Mil.
Selling, General, & Admin. Expense(SGA) was $8.67 Mil.
Total Current Liabilities was $31.46 Mil.
Long-Term Debt & Capital Lease Obligation was $13.71 Mil.
Net Income was $-18.95 Mil.
Gross Profit was $3.29 Mil.
Cash Flow from Operations was $-28.46 Mil.
Total Receivables was $0.62 Mil.
Revenue was $9.29 Mil.
Gross Profit was $9.29 Mil.
Total Current Assets was $149.32 Mil.
Total Assets was $152.40 Mil.
Property, Plant and Equipment(Net PPE) was $2.98 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.45 Mil.
Selling, General, & Admin. Expense(SGA) was $11.87 Mil.
Total Current Liabilities was $55.08 Mil.
Long-Term Debt & Capital Lease Obligation was $14.20 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.222 / 18.111) / (0.619 / 9.293)
=0.012258 / 0.066609
=0.184

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9.293 / 9.293) / (18.111 / 18.111)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (113.444 + 2.2) / 115.729) / (1 - (149.315 + 2.975) / 152.4)
=0.000734 / 0.000722
=1.0166

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18.111 / 9.293
=1.9489

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.45 / (1.45 + 2.975)) / (1.208 / (1.208 + 2.2))
=0.327684 / 0.35446
=0.9245

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.673 / 18.111) / (11.874 / 9.293)
=0.47888 / 1.277736
=0.3748

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((13.714 + 31.456) / 115.729) / ((14.2 + 55.08) / 152.4)
=0.390308 / 0.454593
=0.8586

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-18.946 - 3.29 - -28.455) / 115.729
=0.053738

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Adagene has a M-score of -1.98 suggests that the company is unlikely to be a manipulator.


Adagene Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Adagene's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Adagene (Adagene) Business Description

Traded in Other Exchanges
Address
Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Adagene (Adagene) Headlines

From GuruFocus

Adagene Announces Updates to its Board of Directors

By sperokesalga sperokesalga 04-28-2023

Adagene to Participate in Investor Conferences in May and June

By GuruFocusNews GuruFocusNews 06-21-2022